News Dec 16, 2015 CardioCell Appoints Timothy Brown, J.D., as Vice President of Intellectual Property SAN DIEGO — Dec. 16, 2015 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, today welcomes Timothy M.
Read MoreCardioCell Plans Phase IIb Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure
News Dec 1, 2015 CardioCell Plans Phase IIb Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure SAN DIEGO — Dec. 1, 2015 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, intends to
Read MoreCardioCell CEO Presents at the World Congress of Regenerative Medicine & Stem Cell – Shanghai 2015
News Nov 16, 2015 CardioCell CEO Presents at the World Congress of Regenerative Medicine & Stem Cell – Shanghai 2015 SHANGHAI, CHINA – WORLD CONGRESS OF REGENERATIVE MEDICINE & STEM CELL 2015 – Nov. 16, 2015 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that
Read MoreCardioCell CEO Presents at BIO-Europe 2015
News Oct 28, 2015 CardioCell CEO Presents at BIO-Europe 2015 MUNICH, GERMANY – BIO-EUROPE 2015 – Oct. 28, 2015 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, announces a presentation by CEO Sergey
Read MoreCardioCell Board Members and Clinical Trial Leads Collaborate on Peer-Reviewed Paper Published in the Journal of Cardiovascular Medicine
News Oct 21, 2015 CardioCell Board Members and Clinical Trial Leads Collaborate on Peer-Reviewed Paper Published in the Journal of Cardiovascular Medicine SAN DIEGO — Oct. 21, 2015 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for
Read MoreCardioCell Scientific Advisory Board Chair Presents at the Stem Cells & Regenerative Medicine Congress 2015
News Sep 1, 2015 CardioCell Scientific Advisory Board Chair Presents at the Stem Cells & Regenerative Medicine Congress 2015 WASHINGTON, D.C. – STEM CELLS & REGENERATIVE MEDICINE CONGRESS 2015 – Sept. 1, 2015 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary
Read MoreCardioCell Adds Stony Brook University to Sites Conducting a Phase IIa Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure
News Mar 10, 2015 CardioCell Adds Stony Brook University to Sites Conducting a Phase IIa Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure STONY BROOK, NEW YORK — March 10, 2015 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that designs
Read MoreUniversity of Pennsylvania Doses First Patient in Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy
News Nov 20, 2014 University of Pennsylvania Doses First Patient in Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy PHILADELPHIA — Nov. 20, 2014 — CardioCell LLC, a Stemedica Cell Technologies Inc.
Read More